Data demonstrate potential superiority of a targeted protein degradation strategy compared to kinase inhibition for both BTK and IRAK4 targets in sel ...

The study also showed that the RNA in the COVID-19 virus could incite the production of new immune cells that target and ...

Researchers have discovered that the Covid-19 virus can trigger the immune system to attack cancer cells. The virus's RNA ...

The unassuming yet popular white button mushroom has cancer-fighting abilities, according to the results of a human clinical ...

Detailed price information for Sonnet Biotherapeutics Holdings Inc (SONN-Q) from The Globe and Mail including charting and trades.

Researchers found that the COVID-19 virus triggers immune changes that may one day be harnessed to help fight cancer.

"It's incredible, and a big surprise, that the same infection that caused so much devastation can help create a ...

Immune cells produced during severe COVID-19 infection may shrink tumors. The unexpected mechanism offers a new therapeutic ...

French biotech Innate Pharma is recruiting natural-born killers to target B cell non-Hodgkin lymphoma (B-NHL). | French ...

Investigators at Dana-Farber Cancer Institute are opening a new clinical trial to evaluate a novel type of immune cellular ...

Immunotherapy, which enhances the immune system's T cell response to eliminate cancer cells, has emerged as a key approach in ...

Q3 2024 Earnings Call Transcript November 14, 2024 Affimed N.V. beats earnings expectations. Reported EPS is $-1.03, ...